Pfizer's Weight-Loss Data Just Upends Investor Bets
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
See what results to expect from zero based budgeting and how to monitor progress with clear, actionable metrics.
19,375 articlesPfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Unpack the essentials of fulgent genetics (flgt) earnings in plain language. This guide translates the earnings trans...
A recent insider move at Precigen has many investors asking if a CFO’s share sale signals trouble. This deep-dive bre...
A shift from textbooks to screens and AI in classrooms coincides with a decline in america’s math scores. Experts war...
A disciplined approach to a small Bitcoin allocation could unlock a longer retirement runway. This guide explains how...
As AI accelerates, the question on many investors' minds is will Nvidia stock soar. This article breaks down the driv...
From repeated loan denials to a growing 10+ unit multifamily portfolio, this deal diary-style story reveals the strat...
Fewer Gen Z adults are forming romantic relationships, a trend linked to softer social skills and new onboarding chal...
Amazon plans an unprecedented AI data-center buildout, with a $200 billion capex target for 2026. This article unpack...
As AI data centers surge, the choice between Constellation Energy and Vistra hinges on reliability, cost, and market ...
A Chinese regulator warned of a security backdoor in Anthropic's Claude Code, signaling tightened AI-tool oversight a...
A Sydney-based tech founder uses AI to design a bespoke cancer vaccine for his dog, Rosie, signaling a new frontier i...